Regarding the underlying mechanism for the IL-17 signaling pathway to manipulate tumor progression, previous studies demonstrate that it directly impacts these cells by overseeing the control of inflammatory factors, spurring tumor cell proliferation, fostering the epithelial-to-mesenchymal cell transformation (EMT), upregulating MMP, attracting inflammatory cells to tumor sites, and thwarting the processes of autophagy and cell death [39,40,73,74]. Here, IL17A is linked to neoplasm.